KSK-104
Product Specifications
Target
Antibacterial
Related Pathways
Microbiology/Virology
Bioactivity
KSK-104 exhibits potent antibacterial activity against Mycobacterium tuberculosis, with a minimum inhibitory concentration (MIC) of 0.78 μM. Its mechanism of action primarily involves the synthesis and salvage pathway of pyridoxal 5'-phosphate (PLP), as well as PLP-dependent enzymes and the oxidative stress network. KSK-104 is a promising candidate for developing novel anti-tuberculosis drugs targeted at drug-resistant strains of Mycobacterium tuberculosis.
Molecular Formula
C22H20N2O4
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6502162-01 0.1 mL
T-box 1 (Tbx1, T-box family of transcription factors) (AP)
Sign In for Pricing
View Details MBS6502162-02 5x 0.1 mL
T-box 1 (Tbx1, T-box family of transcription factors) (AP)
Sign In for Pricing
View Details 
orb2919658-01 20 µg
Recombinant Sorghum bicolor CASP-like protein Sb05g025790 (Sb05g025790)
Sign In for Pricing
View Details orb2919658-02 100 µg
Recombinant Sorghum bicolor CASP-like protein Sb05g025790 (Sb05g025790)
Sign In for Pricing
View Details 
222091-01 50 µL
DARPP-32 (Protein Phosphatase 1 Regulatory Subunit 1B, DARPP-32, Dopamine- and cAMP-Regulated neuronal Phosphoprotein, PPP1R1B, DARPP32) discontinued
Sign In for Pricing
View Details